Macrogenics reported $67.1M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Amgen AMGN:US $ 12618M 268M
AstraZeneca AZN:LN 21815M 925M
Biogen BIIB:US $ 5018M 1071.4M
Bristol Myers Squibb BMY:US $ 20915M 1906M
Cerulean Pharma CERU:US $ 16.4M 0.34M
Daiichi Sankyo 4568:JP Y 406816M 11548M
Eli Lilly And LLY:US $ 15620.6M 2234.6M
Epizyme EPZM:US $ 38.97M 6.23M
Genmab GEN:DC DK 1339M 229M
Geron GERN:US $ 46.63M 1.11M
Gilead Sciences GILD:US $ 9220M 662M
Immunogen IMGN:US $ 87.07M 2.95M
Karyopharm Therapeutics KPTI:US $ 62.54M 3.8M
Macrogenics MGNX:US $ 67.1M 7.48M
Mirati Therapeutics MRTX:US $ 119.15M 4.42M
Puma Biotechnology PBYI:US $ 56.83M 17.95M
Regeneron Pharmaceuticals REGN:US $ 3033.9M 26.3M
Seattle Genetics SGEN:US $ 608.52M 77.23M
Xencor XNCR:US $ 75.04M 14.1M